Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2021 Filed Feb 22, 2021 21:32 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000146 · wf-form4_161402953083682.xml · derivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,704 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 6,000 options granted February 19, 2016 at an exercise price of $41.83 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 1,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:32 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 6,000 | $167.88 | $1,007,280.00 |
DisclosureSEC source: 0001555280-21-000146 · wf-form4_161402953083682.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,083 Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:32 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 6,000 | $41.83 | $250,980.00 |
DisclosureSEC source: 0001555280-21-000146 · wf-form4_161402953083682.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:47 UTC |
SCULLY ROBERT WDirector
|
PurchaseCommon Stock | 2,100 | $165.48 | $347,508.00 |
DisclosureSEC source: 0001555280-21-000150 · wf-form4_161412403100072.xml · nonDerivative · entry 3 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 7,590 F4 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $165.25 to $165.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's spouse is a co-trustee of the trust. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:47 UTC |
SCULLY ROBERT WDirector
|
PurchaseCommon Stock | 2,900 | $164.89 | $478,181.00 |
DisclosureSEC source: 0001555280-21-000150 · wf-form4_161412403100072.xml · nonDerivative · entry 2 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 5,490 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $164.25 to $165.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's spouse is a co-trustee of the trust. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:47 UTC |
SCULLY ROBERT WDirector
|
PurchaseCommon Stock | 2,590 | $163.80 | $424,242.00 |
DisclosureSEC source: 0001555280-21-000150 · wf-form4_161412403100072.xml · nonDerivative · entry 1 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 2,590 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $163.26 to $164.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's spouse is a co-trustee of the trust. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC |
Alaix Juan RamonDirector
|
Exercise / conversionStock Option · Derivative | 133,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · derivative · entry 5 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,192 Underlying: Common Stock · 133,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC |
Alaix Juan RamonDirector
|
SaleCommon Stock | 3,000 | $161.76 | $485,280.00 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 4 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,307 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.68 to $161.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC |
Alaix Juan RamonDirector
|
SaleCommon Stock | 63,029 | $160.89 | $10,140,735.81 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,307 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.48 to $161.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC |
Alaix Juan RamonDirector
|
SaleCommon Stock | 67,041 | $160.17 | $10,737,956.97 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,336 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.48 to $160.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 21:59 UTC |
Alaix Juan RamonDirector
|
Exercise / conversionCommon Stock | 133,070 | $73.24 | $9,746,046.80 |
DisclosureSEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:31 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000145 · wf-form4_161402948522749.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,027 Underlying: Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 600 options granted February 14, 2017 at an exercise price of $55.02 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 23,875 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12,2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 8,758 options granted February 10, 2021 at an exercise price of $160.62 per option . Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:31 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 600 | $170.04 | $102,024.00 |
DisclosureSEC source: 0001555280-21-000145 · wf-form4_161402948522749.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,645 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.03 to $170.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:31 UTC |
Chen Heidi C.Executive Vice President
|
Exercise / conversionCommon Stock | 600 | $55.02 | $33,012.00 |
DisclosureSEC source: 0001555280-21-000145 · wf-form4_161402948522749.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2020. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:54 UTC |
Trawicki RomanExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 3,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,466 Underlying: Common Stock · 3,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F4 · derivative.exercise_price: 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option. F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 9,857 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:54 UTC |
Trawicki RomanExecutive Vice President
|
SaleCommon Stock | 4,491 | $165.82 | $744,697.62 |
DisclosureSEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · nonDerivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,623 F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 21:54 UTC |
Trawicki RomanExecutive Vice President
|
Exercise / conversionCommon Stock | 3,285 | $73.24 | $240,593.40 |
DisclosureSEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · nonDerivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:56 UTC |
David GlennChief Financial Officer
|
Exercise / conversionStock Option · Derivative | 26,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · derivative · entry 4 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,510 Underlying: Common Stock · 26,285 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F5 · derivative.exercise_price: 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option. F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F8 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option; and 18,326 options granted February 10, 2021 at an exercise price of $160.62 per option. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:56 UTC |
David GlennChief Financial Officer
|
SaleCommon Stock | 16,285 | $169.35 | $2,757,864.75 |
DisclosureSEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · nonDerivative · entry 3 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,901 F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.00 to $169.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:56 UTC |
David GlennChief Financial Officer
|
SaleCommon Stock | 10,000 | $168.21 | $1,682,100.00 |
DisclosureSEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · nonDerivative · entry 2 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,186 F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.98 to $168.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:56 UTC |
David GlennChief Financial Officer
|
Exercise / conversionCommon Stock | 26,285 | $73.24 | $1,925,113.40 |
DisclosureSEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · nonDerivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:22 UTC |
MCCALLISTER MICHAEL BDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000123 · wf-form4_161360048410255.xml · derivative · entry 3 MCCALLISTER MICHAEL B · CIK 0001018657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:22 UTC |
MCCALLISTER MICHAEL BDirector
|
OtherCommon Stock | 754 | $166.71 | $125,699.34 |
DisclosureSEC source: 0001555280-21-000123 · wf-form4_161360048410255.xml · nonDerivative · entry 2 MCCALLISTER MICHAEL B · CIK 0001018657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,521 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:22 UTC |
MCCALLISTER MICHAEL BDirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000123 · wf-form4_161360048410255.xml · nonDerivative · entry 1 MCCALLISTER MICHAEL B · CIK 0001018657 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:36 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000129 · wf-form4_161360140261552.xml · derivative · entry 2 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:36 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000129 · wf-form4_161360140261552.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:31 UTC |
Reed Willie MDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000126 · wf-form4_161360105947856.xml · derivative · entry 2 Reed Willie M · CIK 0001601695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:31 UTC |
Reed Willie MDirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000126 · wf-form4_161360105947856.xml · nonDerivative · entry 1 Reed Willie M · CIK 0001601695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionPerformance Award Unit · Derivative | 10,145.4088 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · derivative · entry 6 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,145.4088 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,948.8824 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · derivative · entry 5 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,813.5715 Underlying: Common Stock · 6,948.8824 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 4,095 | $166.71 | $682,677.45 |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 4 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,351 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 2,521 | $166.71 | $420,275.91 |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,301 Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:58 UTC |
PECK KRISTIN CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,948 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:24 UTC |
Norden GregoryDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · derivative · entry 3 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:24 UTC |
Norden GregoryDirector
|
OtherCommon Stock | 697 | $166.71 | $116,196.87 |
DisclosureSEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · nonDerivative · entry 2 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,389.2431 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:24 UTC |
Norden GregoryDirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · nonDerivative · entry 1 Norden Gregory · CIK 0001405104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,086.2431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:35 UTC |
SCULLY ROBERT WDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000128 · wf-form4_161360128890786.xml · derivative · entry 3 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:35 UTC |
SCULLY ROBERT WDirector
|
OtherCommon Stock | 997 | $166.71 | $166,209.87 |
DisclosureSEC source: 0001555280-21-000128 · wf-form4_161360128890786.xml · nonDerivative · entry 2 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,589 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:35 UTC |
SCULLY ROBERT WDirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000128 · wf-form4_161360128890786.xml · nonDerivative · entry 1 SCULLY ROBERT W · CIK 0001352881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:16 UTC |
Bisaro PaulDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000120 · wf-form4_161360018202240.xml · derivative · entry 2 BISARO PAUL · CIK 0001237253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:16 UTC |
Bisaro PaulDirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000120 · wf-form4_161360018202240.xml · nonDerivative · entry 1 BISARO PAUL · CIK 0001237253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:29 UTC |
PARENT LOUISE MDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000125 · wf-form4_161360096129044.xml · derivative · entry 3 PARENT LOUISE M · CIK 0001209456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:29 UTC |
PARENT LOUISE MDirector
|
OtherCommon Stock | 997 | $166.71 | $166,209.87 |
DisclosureSEC source: 0001555280-21-000125 · wf-form4_161360096129044.xml · nonDerivative · entry 2 PARENT LOUISE M · CIK 0001209456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,236 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:29 UTC |
PARENT LOUISE MDirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000125 · wf-form4_161360096129044.xml · nonDerivative · entry 1 PARENT LOUISE M · CIK 0001209456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:18 UTC |
DAMELIO FRANK ADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000121 · wf-form4_161360026953953.xml · derivative · entry 3 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:18 UTC |
DAMELIO FRANK ADirector
|
OtherCommon Stock | 887 | $166.71 | $147,871.77 |
DisclosureSEC source: 0001555280-21-000121 · wf-form4_161360026953953.xml · nonDerivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,808 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 22:18 UTC |
DAMELIO FRANK ADirector
|
Exercise / conversionCommon Stock | 2,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000121 · wf-form4_161360026953953.xml · nonDerivative · entry 1 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:33 UTC |
Rhodes LindaDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,779.1458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001555280-21-000127 · wf-form4_161360118931056.xml · derivative · entry 3 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,694.57 Underlying: Common Stock · 2,779.1458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU. F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024. Read SEC document |
| February 13, 2021 Filed Feb 17, 2021 17:33 UTC |
Rhodes LindaDirector
|
OtherCommon Stock | 612 | $166.71 | $102,026.52 |
DisclosureSEC source: 0001555280-21-000127 · wf-form4_161360118931056.xml · nonDerivative · entry 2 Rhodes Linda · CIK 0001336284 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,635 F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.